NEW YORK (Reuters Health) - Parents of preschoolers at risk for attention deficit/hyperactivity disorder (ADHD) may first want to try behavior training before they put their children on medications, ...
The FOCUS-2 trial in children complements the recently announced FOCUS-3 trial in adolescents with ADHDNEW YORK, July 07, 2026 (GLOBE NEWSWIRE) ...
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the first patient has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results